fbpx
A patient with MDR-TB receives bedaquiline, one of the first new TB medicines in nearly 50 years, at the start of the endTB clinical trial in Almaty, Kazakhstan. (Photo by Yekaterina Sahabutdinova / PIH)

Groundbreaking Kazakhstan TB Trial Continuing Amid COVID-19 Challenges

Despite Kazakhstan’s nationwide lockdown that began in March to contain COVID-19, Partners In Health clinicians have continued to examine and provide treatment—in person and online—for tuberculosis patients enrolled in a groundbreaking clinical trial. Clinicians have had to communicate regularly with police to cross checkpoints and have used their own vehicles Read more…

Ribbon cutting ceremony for one of the TB and MDR-TB vans

Eliminating TB, One Van at a Time

The imminent launch of two vans equipped with state-of-the-art technology to test for tuberculosis (TB) and multidrug-resistant tuberculosis (MDR-TB) marks a major milestone for PIH’s and Peru’s fight against TB, the leading infectious killer of adults in the world. Within coming weeks, these trucks will enable PIH to carry out Read more…